Artiva Biotherapeutics Stock
Artiva Biotherapeutics is a biotechnology company dedicated to developing off-the-shelf, allogeneic natural killer (NK) cell therapies that can transform the treatment of cancer. Its innovative approach involves combining its proprietary CAR-NK and NK cell engager platforms to target and eliminate cancer cells effectively.
Founded: 2019
For more Artiva Biotherapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Fred Aslan, MD President and Chief Executive Officer |
| Jennifer Bush Chief Operating Officer |
| Thorsten Graef, MD, Ph.D. Chief Medical Officer |
| Christopher Horan Chief Technical Operations Officer |
| Neha Krishnamohan Chief Financial Officer and EVP, Corporate Development |
